A
ACET
Adicet Bio, Inc. Common Stock
$4.89
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Adicet Bio, Inc. Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$13.02
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: -$1.62
Nov 11
Posts
No posts about ACET yet.
About Adicet Bio, Inc. Common Stock
Adicet Bio is a small biotechnology company that develops cell therapies for cancer and autoimmune diseases. It engineers immune cells to find and attack diseased cells. It has no approved products and no sales to speak of, so it pays its bills with money raised from investors and occasional partnership deals. Its value depends on whether its experimental treatments succeed in clinical trials.